NCT01487564View on ClinicalTrials.gov

Pharmacokinetic Profile of OROS Hydromorphone in Healthy Taiwanese Participants With Different Genotypes for the UGT2B7 Gene

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

Hydromorphone 16 mg

type= exact number, unit= mg, number= 16, format= tablet, route= oral use. One tablet of hydromorphone 16 mg.

Trial Locations (1)

Unknown

Taipei

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT01487564 - Pharmacokinetic Profile of OROS Hydromorphone in Healthy Taiwanese Participants With Different Genotypes for the UGT2B7 Gene | Biotech Hunter | Biotech Hunter